Changes in Beneficial Ownership · 4
Medicus Pharma Ltd.
MDCXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
es260856674_4-mahaffy.xml
Filing details
- Report period
- 2026-11-13
- Issuer
- Medicus Pharma Ltd.
- Issuer CIK
- 0001997296
- Trading symbol
- MDCX
Reporting owner 1
- Name
- MAHAFFY PATRICK J
- Reporting owner CIK
- 0001266569
- Relationship
- Director
- Address
- 300 CONSHOHOCKEN STATE ROAD, SUITE 200, W. CONSHOHOCKEN, PA, 19428
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares, no par value | 2026-11-13 | A · Form 4[F1] | 14,534 | A | 1.72 | 15,243 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- On November 13, 2026, Patrick J. Mahaffy entered into a subscription agreement with the Issuer, pursuant to which Mr. Mahaffy agreed to purchase 14,534 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements.↩ 1
Signature 1
- Signed
- /s/ Raza Bokhari, as Attorney-in-Fact, for Patrick J. Mahaffy
- Date
- 2026-11-17
Company context
We are a clinical-stage, multi-strategy, life science and biotech company focused on investing in and accelerating the clinical development programs of novel and disruptive therapeutic assets. Currently, we are developing two products, SkinJectTM ("SkinJectTM"), with an indication for basal cell carcinoma, and Teverelix trifluoroacetate ("Teverelix", and together with SkinJectTM, the "Products").
Current securities
Recent company filings
- SCHEDULE 13D/A - filed by Bokhari Raza regarding Medicus Pharma Ltd.Nov 17, 2026
- 4 filingNov 17, 2026
- 4 filingNov 17, 2026
- 424B3 filingNov 16, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Material Modification to Rights of Security Holders · Other EventsNov 16, 2026